Skip to main content

Table 1 Clinical information of the 104 participating subjects

From: A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs

Characteristics

No.(%)

All Subjects (N = 104)

 Age years, median (range)

58 (37.25–66.75)

 Gender (male/female)

51/53

NSCLC (N = 49)

 Age years, median (range)

64 (53–69.5)

 Gender (male/female)

26/23

Pathological type

 AC

38 (73.4%)

 SCC

8 (16.30%)

 ASC

3 (6.1%)

 Other

2 (4.1%)

TNM stage

 I

27 (55.1%)

 II

2 (4.1%)

 III

9 (18.4%)

 IV

11 (22.5%)

Benign (N = 31)

 Age years, median (range)

60 (53–66)

 Gender (male/female)

17/14

Healthy (N = 24)

 Age years, median (range)

29 (27.25–31.75)

 Gender (male/female)

8/16

  1. NSCLC non-small cell lung cancer; AC Adenocarcinoma; SCC Squamous carcinoma; ASC adenosquamous carcinoma